The clinical trial demonstrated that Viatom O2Ring pulse oximeter with software platform showed high adherence and potential for long-term OSA monitoring, supporting shared decision-making and expanding OSA management beyond sleep specialists.

etects moderate-to-severe OSA, correlating well with PSG measures. Its low cost and ease of use make it a practical tool for at-home screening and ongoing OSA diagnosis and management.